Page last updated: 2024-12-06

secoverine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

secoverine: RN given refers to parent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID42470
CHEMBL ID2105414
SCHEMBL ID457590
MeSH IDM0090972

Synonyms (28)

Synonym
secoverine
PDSP1_000641
PDSP2_000636
1-cyclohexyl-4-(ethyl-(p-methoxy-alpha-methylphenethyl)amino)-1-butanone
du 23849
1-butanone, 1-cyclohexyl-4-(ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)-
secoverina [inn-spanish]
1-cyclohexyl-4-(ethyl(p-methoxy-alpha-methylphenethyl)amino)-1-butanone
1-cyclohexyl-4-(ethyl-(1-(4-methoxyphenyl)-2-poropyl)amino)-1-butanon
secoverinum [inn-latin]
secoverine [inn]
L001295
1-cyclohexyl-4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butan-1-one
bdbm81800
nsc_42470
cas_57558-44-8
CHEMBL2105414
secoverina
unii-512wjg3i0o
512wjg3i0o ,
57558-44-8
secoverinum
1-cyclohexyl-4-(ethyl(p-methoxy-.alpha.-methylphenethyl)amino)-1-butanone
119515-08-1
SCHEMBL457590
Q27260853
EX-A6158
DTXSID90866632

Research Excerpts

Effects

ExcerptReferenceRelevance
"6. Secoverine has no nicotinolytic or antihistaminic activity, a moderate antisterotonic activity, an inhibiting effect on the noradrenaline uptake mechanism of the vas deferens and a marked local anaesthetic activity."( Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects.
Claassen, V; Zwagemakers, JM, 1980
)
1.12

Actions

ExcerptReferenceRelevance
"5. Secoverine did not cause ulceration of the stomach wall of the rat during acute or prolonged oral administration of high doses."( Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
Claassen, V; Zwagemakers, JM, 1980
)
1.12
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (79.17)18.7374
1990's4 (16.67)18.2507
2000's1 (4.17)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.70 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index3.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]